This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Beth Israel Deaconess Medical Center, Inc., Csl Behring Ag. Active years: 2018.
Company Filing History:
1 out of 536 
1 out of 28 
Years Active: 2018
Title: Sandra Wymann - Innovator in Complement Inhibition
Introduction
Sandra Wymann is an accomplished inventor based in Muensingen, Switzerland. She is currently associated with Csl Limited, where she contributes her expertise in the field of complement inhibition. Although she has not yet been granted any patents, her work is significant in advancing medical science.
Latest Patent Applications
Sandra Wymann's latest patent application is titled "Soluble Complement Receptor Type I Variants and Uses Thereof." This application describes a method of inhibiting complement activity in a subject by administering a soluble complement receptor type 1 (sCR1) variant. This innovative approach has the potential to impact therapeutic strategies significantly.
Conclusion
Sandra Wymann is a promising inventor whose work in complement inhibition could lead to important advancements in medical treatments. Her contributions, although not yet reflected in granted patents, showcase her dedication to innovation in the field.